Clinical Research Services Market By Type of Service (Treatment Research, Prevention Research, Diagnostic Research, Screening Research, Quality of Life Research, Genetic studies, Epidemiological studies, Clinical Trials, Others), By Disease Area (Oncology, Central Nervous System Disorders, Cardio Vascular Disorders, Diabetes, Infectious Diseases, Others), By End User (Pharmaceutical Companies, Biotechnological Companies, Research Organizations, Others) and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Clinical Research Services Market size was valued at USD 47.06 billion in 2021 and expected to reach a value of USD 88.32 billion by 2028, growing at a CAGR of 9.41% during the forecast period 2022-2028. Clinical research is a branch of healthcare that studies whether a medical strategy, medicine, medical device, diagnostics and treatment regimes is safe and effective for human use. Clinical research may contribute to treatment, prevention, diagnosis or relieving certain symptoms of disease or condition. Clinical research is carried out with a pool of patients or people under study condition. Clinical research is a broad term which includes many research studies such as treatment, prevention, diagnostic, screening, genetic, epidemiological and clinical trial studies. Clinical research services market is at steady stage of growth. The market is expected to grow at a significant rate during the forecast period. Market players are expanding their markets by offering various services and collaborations. For instance in June 2017, PAREXEL International Corporation, a leading global biopharmaceutical services organization, collaborated with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials. Moreover, In order to maintain market position, companies adopting mergers and acquisitions as their key strategies. For instance, in May, 2017 and inVentiv Health, Inc. and INC Research Holdings, Inc., announced a definitive merger agreement to create a leading biopharmaceutical solutions organization. Similarly, in April 2016, Charles River Laboratories acquired WIL Research to enhance its global footprint, scientific capabilities, and access to growing market segments.

Global Clinical Research Services Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Clinical Research Services Market Dynamics

Global clinical research services market is driven by increased burden of chronic diseases such as HIV, cancer and cardio vascular diseases, which requires huge investments. Pharmaceutical and biotechnological companies outsource their clinical research activities to clinical research service organizations to reduce the cost and regulatory burdens. In addition, enormous growth in biopharmaceutical segment, discovery of the new drugs through innovation and increase in clinical trials are expected to boost the clinical research services market over the forecast period. However, increase in clinical research costs, stringent regulatory procedures and ethical issues are hindering the clinical research services market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Clinical Research Services Market Segmentation

Type of service
  • Treatment Research
  • Prevention Research
  • Diagnostic Research
  • Screening Research
  • Quality of LifeResearch
  • Genetic studies
  • Epidemiological studies
  • Clinical Trials
  • Others
Disease Area
  • Oncology
  • Central Nervous System Disorders
  • Cardio Vascular Disorders
  • Diabetes
  • Infectious Diseases
  • Others
  • Pharmaceutical Companies
  • Biotechnological Companies
  • Research Organizations
  • Others

Frequently Asked Questions

The clinical research services market is projected to expand at a CAGR of 9.41% during the forecast period

Quintiles Transnational Holdings Inc. (U.S.), PAREXEL International Corporation (U.S.), ICON Plc (Ireland), PRA Health Sciences, Inc. (U.S.), InVentiv Health Inc. (U.S.), Wuxi AppTec (Cayman) Inc. (China)

North America is the fastest-growing region for clinical research services market

[urltag url='request-table-of-content']

  • Laboratory Corporation Of America Holdings (U.S.)
  • Quintiles Transnational Holdings Inc. (U.S.)
  • PAREXEL International Corporation (U.S.)
  • ICON Plc (Ireland)
  • PRA Health Sciences, Inc. (U.S.)
  • InVentiv Health Inc. (U.S.)
  • Wuxi AppTec (Cayman) Inc. (China)
  • Pharmaceutical Product Development, LLC (U.S.)
  • INC Research Holdings Inc. (U.S.)
  • Charles River Laboratories International Inc. (U.S.)